Bonaire, Sint Eustatius and Saba vs Fiji: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology

Bonaire, Sint Eustatius and Saba
0.2%
in 2024
Fiji
0.2%
in 2024
Bonaire, Sint Eustatius and Saba rank
98th
Fiji rank
98th

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time

  • Bonaire, Sint Eustatius and Saba
  • Fiji
00.10.20.30.4201520192024

How they compare

Bonaire, Sint Eustatius and Saba currently reports 0.2% against 0.2% in Fiji, a difference of 0.0%.

The two have swapped places 3 times across 10 shared years of data; in 2015 it was Bonaire, Sint Eustatius and Saba ahead.

Bonaire, Sint Eustatius and Saba ranks 98th and Fiji ranks 98th of 246 countries.

Across the 2 decades both report, Bonaire, Sint Eustatius and Saba averaged higher in 1 and Fiji in 1.

Head to head by decade

Decade Bonaire, Sint Eustatius and Saba Fiji Difference Ahead
2010s 0.3% 0.3% 0.0% Bonaire, Sint Eustatius and Saba
2020s 0.2% 0.3% 0.1% Fiji

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bonaire, Sint Eustatius and Saba or Fiji?
Bonaire, Sint Eustatius and Saba, at 0.2% against 0.2% in Fiji as of 2024.
What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bonaire, Sint Eustatius and Saba and Fiji?
0.0%, with Bonaire, Sint Eustatius and Saba ahead.
How many years of comparable data are there for Bonaire, Sint Eustatius and Saba and Fiji?
10 years are reported by both, from 2015 to 2024.
How do Bonaire, Sint Eustatius and Saba and Fiji rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Bonaire, Sint Eustatius and Saba ranks 98th and Fiji ranks 98th of 246 countries.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Bonaire, Sint Eustatius and Saba vs Fiji: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 05 September 2026, from https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/bonaire-sint-eustatius-and-saba-2/fiji/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/bonaire-sint-eustatius-and-saba-2/fiji/">Bonaire, Sint Eustatius and Saba vs Fiji: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
250 places, 2,500 data points, 2015–2024
Last refreshed